RIMOLDI, VALERIA
 Distribuzione geografica
Continente #
EU - Europa 2.739
NA - Nord America 1.901
AS - Asia 1.000
SA - Sud America 52
Continente sconosciuto - Info sul continente non disponibili 17
AF - Africa 11
OC - Oceania 8
Totale 5.728
Nazione #
US - Stati Uniti d'America 1.835
GB - Regno Unito 1.110
CN - Cina 477
IT - Italia 374
DE - Germania 335
SE - Svezia 326
SG - Singapore 160
TR - Turchia 127
RU - Federazione Russa 111
UA - Ucraina 108
IE - Irlanda 92
EU - Europa 88
KR - Corea 88
IN - India 70
FR - Francia 69
CA - Canada 65
FI - Finlandia 59
NL - Olanda 58
CO - Colombia 41
BE - Belgio 23
JP - Giappone 18
PL - Polonia 17
ID - Indonesia 16
GR - Grecia 13
DK - Danimarca 11
HK - Hong Kong 11
VN - Vietnam 10
AU - Australia 6
BR - Brasile 6
CH - Svizzera 6
NO - Norvegia 6
CZ - Repubblica Ceca 4
ES - Italia 4
IQ - Iraq 4
IR - Iran 3
RO - Romania 3
TW - Taiwan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
CI - Costa d'Avorio 2
CL - Cile 2
HU - Ungheria 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
TH - Thailandia 2
TN - Tunisia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
GH - Ghana 1
GM - Gambi 1
IL - Israele 1
JO - Giordania 1
LU - Lussemburgo 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
NG - Nigeria 1
PK - Pakistan 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 5.800
Città #
Southend 1.058
Chandler 264
Seattle 143
Beijing 142
Wilmington 131
Milan 126
Princeton 113
Singapore 104
Ashburn 98
Dublin 91
Jacksonville 88
Frankfurt am Main 84
Ann Arbor 78
Somerville 70
Redmond 66
Mountain View 52
Nanjing 52
Fairfield 51
Toronto 47
Serra 45
Andover 39
Bogotá 39
Sakarya 39
Dearborn 38
Boardman 37
Des Moines 34
Bengaluru 32
Houston 32
Shanghai 32
Woodbridge 32
Hanover 31
Berlin 30
Cambridge 24
Medford 19
New York 17
Guangzhou 15
Jinan 15
Warsaw 15
Chengdu 14
Falls Church 14
Helsinki 14
Istanbul 14
Shenyang 14
Athens 13
Brussels 13
Phoenix 13
Wuhan 12
Mumbai 11
Nanchang 11
Santa Clara 11
Sunnyvale 11
Tianjin 11
Eitensheim 10
Hebei 10
Dong Ket 8
Hamburg 8
Ottawa 8
Roxbury 8
Waanrode 8
Bühl 7
Jakarta 7
Kunming 7
Redwood City 7
San Diego 7
Cagliari 6
Changsha 6
Hangzhou 6
Hong Kong 6
Munich 6
Norwalk 6
Odernheim 6
Verona 6
Bitonto 5
Fremont 5
Fuzhou 5
Haikou 5
Rome 5
Turin 5
Zhengzhou 5
Ankara 4
Bethesda 4
Grafing 4
London 4
Naples 4
Ningbo 4
Oslo 4
Pisa 4
São Paulo 4
Ancona 3
Brisbane 3
Brooklyn 3
Chicago 3
Chicoutimi 3
Denver 3
Durham 3
Erbil 3
Jesi 3
Kiez 3
Los Angeles 3
Meda 3
Totale 3.849
Nome #
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 390
The GBAP1 pseudogene acts as a ceRNA for the glucocerebrosidase gene GBA by sponging miR-22-3p 192
The double-faced association of the PRKCA gene with multiple sclerosis 181
Dual role of G-runs and hnRNP F in the regulation of a mutation-activated pseudoexon in the fibrinogen gamma-chain transcript 180
Gene regulation in the pathogenesis of angioedema due to inherited c1 inhibitor deficiency (hereditary angioedema) 175
Recettore dell’ossitocina e regolazione della proliferazione cellulare: ruolo della localizzazione in microdomini di membrana 166
Mutational screening and functional analyses in the zebrafish model of GIGYF2 as a candidate gene for Parkinson disease 151
Analysis of the structural effects of four novel and a previously known mutations causing factor XI deficiency 150
Gene regulation in the pathogenesis of inherited C1-inhibitor deficiency (Hereditary Angioedema) 146
Mutational screening and functional analyses in the zebrafish model of GIGYF2 as a candidate gene for Parkinson disease 143
Association and functional analyses of MEF2A as a susceptibility gene for premature myocardial infarction and coronary artery disease 141
Characterization of productive and unproductive mRNA splicings in F11 : identification of a novel coagulation isoform 140
Functional analysis of missense mutations in the Myocyte Enhancer Factor 2A (MEF2A) gene do not support their causal role in the pathogenesis of myocardial infarction 129
Characterization of the F11 alternative splicing pattern : identification of a novel coagulation FXI isoform 126
Response: Further thoughts on the "phantom" delta6/7 FXI isoform 126
Mutational screening and Zebrafish functional analysis of Gigyf2 as a Parkinson-disease gene 121
Characterization of productive and unproductive mRNA splicings in F11 : identification of a novel coagulation FXI isoform 120
The oxytocin receptor antagonist atosiban inhibits cell growth via a "biased agonist" mechanism 117
Identificazione e caratterizzazione del pattern di splicing alternativo del gene F11 e di una nuova isoforma FXI della coagulazione 116
Dowregulation of the oxytocin receptor after ligand binding 115
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 114
The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33 113
Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localisation in caveolin-1 enriched domains 108
Effects of cholesterol manipulation on the signaling of the human oxytocin receptor 107
Characterization of the genetic basis of FXI deficiency in fourteen unrelated patients 106
Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localisation in caveolin-1 microdomains 106
The Proprotein Convertase Subtilisin-Kexin type 9 (PCSK9) R46L variant is associated with reduced serum low-density lipoprotein cholesterol (LDL-C) in the Italian population 105
The role of the Myocyte Enhancer Factor 2A (MEF2A) gene in the pathogenesis of myocardial infarction 105
Evidence of Liquid Crystal–Assisted Abiotic Ligation of Nucleic Acids 102
Molecular characterization of in-frame and out-of-frame alternative splicings in coagulation factor XI pre-mRNA 102
Oxytocin-induced cell growth proliferation in human mymetrial cells and leiomyomas 100
The Proprotein Convertase Subtilisin-Kexin Type 9 (PCSK9) R46L variant is associated with reduced serum low-density lipoprotein cholesterol in the Italian population 99
Functional characterization of two novel splicing mutations in the OCA2 gene associated with oculocutaneous albinism type II 99
Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis 99
Synergistic antiproliferative effects of the piperidine nitroxide TEMPOL and Temozolomide against human glioma cell lines 94
Oxytocin-mediated control of cell proliferation : role of oxytocin receptor localization in lipid rafts 93
Localization in caveolin-1 enriched domains modulates the oxytocin receptor mediated effects on cell growth 93
Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localisation in caveolin-1 enriched domains 93
Characterization of the genetic basis of FXI deficiency in two Turkish patients 93
A novel factor XI missense mutation (Val371Ile) in the activation loop is responsible for a case of mild type II factor XI deficiency 92
The nitroxide TEMPOL induces oxidative stress, p21WAF1/CIP1, and cells death in HL60 cells 91
Modulation of anthracycline resistance by the nitroxide TEMPOL in human carcinoma cells 90
Modulation of the oxytocin receptor signaling by rafts localisation 86
Profiling the mutational landscape of coagulation factor V deficiency 85
The piperidine nitroxide TEMPOL : a new antiproliferative agent for the therapy of gliomas? 84
Rafts localization modulates the oxytocin receptor signaling 83
The piperidine nitroxide TEMPOL inhibits in vitro and in vivo growth of glioma cells 82
Hupf1 and hupf2 knockdown by RNA interference in HEPG2 cells as a model to study nonsense-mediated mRNA decay modulation of coagulation-gene expression 80
Exploring the global landscape of genetic variation in coagulation factor XI deficiency 80
DNAJC12 and dopa-responsive nonprogressive parkinsonism 62
Glucocerebrosidase mutations in primary parkinsonism 58
Molecular investigation of 41 patients affected by coagulation factor XI deficiency 41
Role of Lysosomal Gene Variants in Modulating GBA-Associated Parkinson's Disease Risk 26
The SPID-GBA study: Sex distribution, penetrance, incidence, and dementia in GBA-PD 23
Screening of LRP10 mutations in Parkinson's disease patients from Italy 15
Totale 6.134
Categoria #
all - tutte 17.883
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.883


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020416 0 0 0 27 22 60 45 53 95 65 28 21
2020/2021759 19 74 83 10 67 67 35 43 69 87 155 50
2021/2022735 58 40 33 29 48 67 68 31 89 96 36 140
2022/2023861 95 87 81 114 104 164 29 58 75 7 37 10
2023/2024583 18 57 40 44 158 34 35 42 9 36 47 63
2024/2025222 39 121 29 33 0 0 0 0 0 0 0 0
Totale 6.134